Discerning the effects of psychopathology and antidepressant treatment on sexual dsyfunction

Basit Öğe Kaydı
dc.authorid0000-0001-5207-6240en_US
dc.contributor.authorTufan, Ali Evren
dc.contributor.authorÖzten, Eylem
dc.contributor.authorIşık, Sibel
dc.contributor.authorCerit, Cem
dc.date.accessioned2021-06-23T19:34:22Z
dc.date.available2021-06-23T19:34:22Z
dc.date.issued2013
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractObjective. To compare the frequency and correlates of sexual dysfunction in patients with Major Depressive Disorder on SSRI treatment with those who are not. Methods. Patients diagnosed with Major Depressive Disorder, without comorbid psychopathology/medical disorder/alcohol/nicotine use for the past year with a CGI-S severity score of 4 were included. Two groups were formed, one using SSRIs at least for 6 weeks before the study, and another who were free of drugs for the last month. Arizona Sexual Experience Scale (ASEX) was given to determine sexual dysfunction. P was set at 0.05. Results. Thirty-three patients (25 female, 75.8%) were included. The study group was using sertraline (n = 10, 52.6%) and citalopram (n = 9, 47.4%). Fourteen patients on SSRIs (73.7%) and 12 controls (% 85.7) displayed sexual dysfunction with no difference between groups. Female gender was associated with sexual dysfunction, regardless of treatment (P = 0.04). Arousal sub-test of ASEX differed significantly in the group with dysfunction (P = 0.04). Conclusions. Female gender may be a risk factor for sexual dysfunction in the presence of depression, regardless of drug use. Arousal may be affected in patients, regardless of treatment, and this may reflect the effect of depressive cognitions on libido.en_US
dc.identifier.doi10.3109/13651501.2012.704382
dc.identifier.endpage226en_US
dc.identifier.issn1365-1501
dc.identifier.issn1471-1788
dc.identifier.issue3en_US
dc.identifier.pmid22746989en_US
dc.identifier.scopus2-s2.0-84883195364en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage223en_US
dc.identifier.urihttps://doi.org/10.3109/13651501.2012.704382
dc.identifier.urihttps://hdl.handle.net/20.500.12491/7487
dc.identifier.volume17en_US
dc.identifier.wosWOS:000323528700010en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorTufan, Ali Evren
dc.language.isoenen_US
dc.publisherInforma Healthcareen_US
dc.relation.ispartofInternational Journal Of Psychiatry In Clinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDepressionen_US
dc.subjectSexual Dysfunctionen_US
dc.subjectAntidepressantsen_US
dc.subjectSSRIsen_US
dc.titleDiscerning the effects of psychopathology and antidepressant treatment on sexual dsyfunctionen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
ali-evren-tufan-7487.pdf
Boyut:
254.03 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/Full text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu